The recall involves Lot# GMML24026A (NDC# 29300-415-19) with an expiration date of September 2027. Unichem Pharmaceuticals is recalling 1 lot of Cyclobenzaprine Hydrochloride Tablets USP, 10mg due to ...

If you’re looking at treatment options for muscle spasms you may want to learn more about cyclobenzaprine (Amrix, Fexmid). It’s a generic prescription drug used along with physical therapy and rest to ...

08/27/2025– East Brunswick, NJ, Unichem Pharmaceuticals (USA), Inc. is voluntarily recalling one (1) lot of Cyclobenzaprine Hydrochloride Tablets USP 10 mg, to the consumer level. The Cyclobenzaprine ...

Cyclobenzaprine is a generic prescription oral tablet used to treat muscle spasms. It does not come in any brand-name versions. Cyclobenzaprine can cause mild to serious side effects, including ...

A nationwide recall has been initiated by Unichem Pharmaceuticals due to a significant pill mix-up. Certain bottles of Cyclobenzaprine Hydrochloride Tablets, intended as a muscle relaxant, were ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A sublingual tablet form of the muscle relaxant ...

Unichem Laboratories subsidiary Unichem Pharmaceuticals (USA) Inc. is recalling one lot of muscle relaxant drug Cyclobenzaprine Hydrochloride Tablets USP 10 mg to the consumer level in the U.S. in the ...

An urgent recall has been issued for medication that's been mislabeled, leading the FDA to warn that some Americans could suffer life-threatening reactions if they consume the incorrect pills. New ...

Cyclobenzaprine has possible interactions with alcohol, some other drugs, and certain supplements. Examples include opioids and certain antidepressants. Talk with your doctor to avoid potentially ...

Cyclobenzaprine is a generic drug that’s prescribed for muscle spasms. As with other drugs, cyclobenzaprine can cause side effects, such as drowsiness and anxiety. Cyclobenzaprine oral tablets are not ...

Please provide your email address to receive an email when new articles are posted on . Tonmya significantly reduced daily pain vs. placebo in a phase 3 trial in fibromyalgia. Fast track designation ...